{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T05:49:29Z","timestamp":1763444969824},"reference-count":18,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1016\/j.euroneuro.2010.10.008","type":"journal-article","created":{"date-parts":[[2010,11,30]],"date-time":"2010-11-30T11:01:41Z","timestamp":1291114901000},"page":"282-286","source":"Crossref","is-referenced-by-count":14,"title":["Amisulpride vs. fluoxetine treatment of Chronic Fatigue Syndrome: A pilot study"],"prefix":"10.1016","volume":"21","author":[{"given":"Matteo","family":"Pardini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Guida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Primavera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Krueger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonardo","family":"Cocito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonardo Emberti","family":"Gialloreti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.euroneuro.2010.10.008_bb0005","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s00213-009-1521-8","article-title":"Amisulpride is a potent 5-HT7 antagonist: relevance for antidepressant actions in vivo","volume":"205","author":"Abbas","year":"2009","journal-title":"Psychopharmacology"},{"issue":"Pt 8","key":"10.1016\/j.euroneuro.2010.10.008_bb0010","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1093\/brain\/awn140","article-title":"Increase in prefrontal cortical volume following cognitive behavioural therapy in patients with chronic fatigue syndrome","volume":"131","author":"de Lange","year":"2008","journal-title":"Brain"},{"issue":"12","key":"10.1016\/j.euroneuro.2010.10.008_bb0015","doi-asserted-by":"crossref","first-page":"953","DOI":"10.7326\/0003-4819-121-12-199412150-00009","article-title":"The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group","volume":"121","author":"Fukuda","year":"1994","journal-title":"Ann. Intern. Med."},{"issue":"3","key":"10.1016\/j.euroneuro.2010.10.008_bb0020","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1185\/030079902125000363","article-title":"Focus on amisulpride","volume":"18","author":"Green","year":"2002","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.euroneuro.2010.10.008_bb0025","series-title":"ECDEU Assessment Manual for Psychopharmacology","year":"1976"},{"issue":"9","key":"10.1016\/j.euroneuro.2010.10.008_bb0030","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.tips.2004.07.002","article-title":"Functional, molecular and pharmacological advances in 5-HT7 receptor research","volume":"25","author":"Hedlund","year":"2004","journal-title":"Trends Pharmacol. Sci."},{"issue":"10","key":"10.1016\/j.euroneuro.2010.10.008_bb0035","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1001\/archneur.1989.00520460115022","article-title":"The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus","volume":"46","author":"Krupp","year":"1989","journal-title":"Arch. Neurol."},{"issue":"7","key":"10.1016\/j.euroneuro.2010.10.008_bb0040","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1177\/014107689809100706","article-title":"Screening instruments for psychiatric morbidity in chronic fatigue syndrome","volume":"91","author":"Morriss","year":"1998","journal-title":"J. R. Soc. Med."},{"issue":"10","key":"10.1016\/j.euroneuro.2010.10.008_bb0045","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1517\/14656560902988510","article-title":"Pharmacological treatment of chronic fatigue syndrome: focusing on the role of antidepressants","volume":"10","author":"Pae","year":"2009","journal-title":"Expert Opin. Pharmacother."},{"issue":"9","key":"10.1016\/j.euroneuro.2010.10.008_bb0050","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1212\/WNL.0b013e3181d25b6b","article-title":"Ventromedial prefrontal cortex modulates fatigue after penetrating traumatic brain injury","volume":"74","author":"Pardini","year":"2010","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.euroneuro.2010.10.008_bb0055","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0165-0327(01)00327-5","article-title":"A comparison of paroxetine and amisulpride in the treatment of dysthymic disorder","volume":"70","author":"Rocca","year":"2002","journal-title":"J. Affect. Disord."},{"issue":"4","key":"10.1016\/j.euroneuro.2010.10.008_bb0060","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1177\/147323000102900407","article-title":"Sulpiride in the treatment of somatoform disorders: results of a European observational study to characterize the responder profile","volume":"29","author":"Rouillon","year":"2001","journal-title":"J. Int. Med. Res."},{"key":"10.1016\/j.euroneuro.2010.10.008_bb0065","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1097\/00005650-200011000-00008","article-title":"Reliability and validity of the SF-12 health survey among people with severe mental illness","volume":"38","author":"Salyers","year":"2000","journal-title":"Med. Care"},{"issue":"1\u20132","key":"10.1016\/j.euroneuro.2010.10.008_bb0070","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0925-4927(02)00031-8","article-title":"SPECT imaging, clinical features, and cognition before and after low doses of amisulpride in schizophrenic patients with the deficit syndrome","volume":"115","author":"Vaiva","year":"2002","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.euroneuro.2010.10.008_bb0075","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/00005650-199603000-00003","article-title":"A 12 Item Short Form Health Survey: construction of scales and preliminary tests of reliability and validity","volume":"34","author":"Ware","year":"1996","journal-title":"Med. Care"},{"issue":"2","key":"10.1016\/j.euroneuro.2010.10.008_bb0080","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/00131746-200603000-00002","article-title":"Self-rated global measure of the frequency, intensity, and burden of side effects","volume":"12","author":"Wisniewski","year":"2006","journal-title":"J. Psychiatr. Pract."},{"issue":"2","key":"10.1016\/j.euroneuro.2010.10.008_bb0085","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/00004714-200104000-00013","article-title":"In vivo extrastriatal and striatal D2 dopamine receptor blockade by amisulpride in schizophrenia","volume":"21","author":"Xiberas","year":"2001","journal-title":"J. Clin. Psychopharmacol."},{"issue":"6","key":"10.1016\/j.euroneuro.2010.10.008_bb0090","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","article-title":"The hospital anxiety and depression scale","volume":"67","author":"Zigmond","year":"1983","journal-title":"Acta Psychiatr. Scand."}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X1000235X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X1000235X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,6]],"date-time":"2019-06-06T17:30:14Z","timestamp":1559842214000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X1000235X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":18,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["S0924977X1000235X"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2010.10.008","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,3]]}}}